ASO Visual Abstract: Biopsy-Guided Pathological Response Assessment in Breast Cancer is Insufficient–Additional Pathology Findings of the MICRA Trial

Annemiek K. E. van Hemert,Frederieke H. van Duijnhoven,Ariane A. van Loevezijn,Claudette E. Loo,Terry Wiersma,Emilie J. Groen,Marie-Jeanne T. F. D. Vrancken Peeters

Annals of surgical oncology（2023）

引用 0|浏览5

暂无评分

摘要

Although the extent of residual invasive disease is small in TN and HER2+ subtypes, substantial residual invasive disease is left behind in all subtypes with 14G biopsies. This may hamper local control and limits adjuvant systemic treatment options. Therefore, surgical excision remains obligatory until accuracy of imaging and biopsy techniques improve.

查看译文

关键词

breast cancer,pathological response assessment,micra trial,insufficient–additional pathology findings,biopsy-guided

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要